Cargando…

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer

SIMPLE SUMMARY: Breast cancer (BC) is a common malignancy with molecular diversity, i.e., heterogeneity. Aside from routine clinical treatments, such as chemotherapy and radiotherapy, which have side effects and tumor resistance, troubling patients and doctors, targeted therapy based on molecular cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaolu, Liu, Kuai, Lu, Shuli, He, Weina, Du, Zixiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656512/ https://www.ncbi.nlm.nih.gov/pubmed/36358874 http://dx.doi.org/10.3390/cancers14215456

Ejemplares similares

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
por: Kudelova, Eva, et al.
Publicado: (2022)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022)

Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020)

Breast cancer heterogeneity and its implication in personalized precision therapy
por: Guo, Liantao, et al.
Publicado: (2023)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
por: Sambi, Manpreet, et al.
Publicado: (2017)

Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer
por: Jin, Hongzhong, et al.
Publicado: (2023)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Targeting Both Autophagy and Immunotherapy in Breast Cancer Treatment
por: Giannopoulos, Spyridon, et al.
Publicado: (2022)

Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
por: Feng, Xiao-Chen, et al.
Publicado: (2023)

Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
por: Xiong, Dian, et al.
Publicado: (2023)

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy
por: Sangaletti, Sabina, et al.
Publicado: (2021)

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

Novel targeted therapies and immunotherapy for advanced thyroid cancers
por: Naoum, George E., et al.
Publicado: (2018)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022)

Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
por: Yan, Tianqing, et al.
Publicado: (2023)

Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Breast cancer organoids and their applications for precision cancer immunotherapy
por: Guan, Dandan, et al.
Publicado: (2023)

Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy
por: Dummer, Reinard
Publicado: (2015)

Melanogenesis and the Targeted Therapy of Melanoma
por: Li, Cang, et al.
Publicado: (2022)

Breast Cancer Heterogeneity
por: Fumagalli, Caterina, et al.
Publicado: (2021)

Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
por: El-Sayes, Nader, et al.
Publicado: (2021)

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
por: Tsoutsou, Pelagia G., et al.
Publicado: (2018)

Research progress in targeted therapy and immunotherapy for gastric cancer
por: Li, Xuewei, et al.
Publicado: (2022)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
por: Kerr, Caroline P., et al.
Publicado: (2022)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2021)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies
por: Benjamin, David J, et al.
Publicado: (2023)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer
por: Lin, Mingen, et al.
Publicado: (2023)

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
por: Du, Wenwen, et al.
Publicado: (2017)

Immunotherapy in breast cancer
por: Bayraktar, Soley, et al.
Publicado: (2019)

12 MULTIFOCAL INTRAHEPATIC CHOLANGIOCARCINOMA: IMMUNOGENOMIC AND EPIGENOMIC HETEROGENEITIES INFLUENCE THE RESPONSES TO TARGETED THERAPY AND IMMUNOTHERAPY
por: Chen, Shu-Ling, et al.
Publicado: (2021)

Gene therapy for carcinoma of the breast: Genetic immunotherapy
por: Strong, Theresa V
Publicado: (2000)

Immunology and immunotherapy in breast cancer
por: Semiglazov, Vladimir, et al.
Publicado: (2022)

Breast Cancer Immunotherapy: An Update
por: Makhoul, Issam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgarrp59bm4s7mcmel1ab9ka7o